Anti-Obesity Drugs Market Growth Analysis Report 2019: Alizyme, Boehringer Ingelheim GmbH, Novo Nordisk A/S, Pfizer, Shionogi, Merck

Pharmacological agents which are used to reduce the body weight by losing the amount of cholesterol in body are called as Anti-obesity drugs. Anti-Obesity drugs alter the fundamental functions of human body by altering the appetite or by consuming the calories.

Anti-Obesity Drugs Market to 2027 - Global Analysis and Forecasts By Drug Class ( Peripherally Acting Anti-obesity Drugs, Centrally Acting Anti-obesity Drugs ); Medication ( Monotherapies, Polytherapies ); Drug Type ( Prescription Drugs, OTC Drugs ), and Geography

The Anti-Obesity Drugs market is anticipated to grow in the forecast period owing to driving factors such as adoption of sedentary lifestyle, increasing prevalence of obesity, introduction of novel anti-obesity drugs, chronic nature of disease, and increasing aging population.

Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00006850?utm_source=OpenPR&utm_medium=Simran

The global Anti-Obesity Drugs market is segmented on the basis of drug class, medication, and drug type. Based on drug class, the market is segmented into Peripherally Acting Anti-obesity Drugs, and Centrally Acting Anti-obesity Drugs. Based on medication, the market is segmented into Monotherapies and Polytherapies. Based on drug type, the market is segmented into Prescription Drugs and OTC Drugs.

Companies Listed are -

1. Arena Pharmaceuticals, Inc.
2. F. Hoffmann-La Roche Ltd
3. GlaxoSmithKline plc
4. Alizyme plc
5. Boehringer Ingelheim GmbH
6. Novo Nordisk A/S
7. Pfizer Inc
8. Shionogi Inc.
9. Merck and Co., Inc.
10. Norgine B.V.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Anti-Obesity Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Anti-Obesity Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Anti-Obesity Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anti-Obesity Drugs market in these regions.

The "Global Anti-Obesity Drugs Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anti-Obesity Drugs market with detailed market segmentation by drug class, medication, drug type, and geography. The global Anti-Obesity Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Anti-Obesity Drugs market players and offers key trends and opportunities in the market.

Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00006850?utm_source=OpenPR&utm_medium=Simran

Contact us –
Phone : +1-646-491-9876
Email Id : sales@theinsightpartners.com
Website: https://www.theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

This release was published on openPR.